EGFR and neoplasm: Masking phosphatidylserine (PS), present in the membrane surface of EVs, by Diannexin and blocking its receptor TIM4 inhibits epidermal growth factor receptor (EGFR) transfer from tumor EVs to endothelial cells resulting in reduced tumor growth and microvascular density in vivo (80).